ANALYSIS OF CURRENT AND EMERGING THERAPIES FOR INSOMNIA WEB ACTIVITY- Insomnia is a leading cause of absenteeism, accidents, and errors in the workplace. Overall direct and indirect costs related to insomnia exceed $30 billion annually. A significant portion of these costs are attributable to patients with conditions comorbid to insomnia, which include mood and anxiety disorders; chronic pain; respiratory, urinary, and neurologic conditions; diabetes mellitus; and cardiovascular disease.
Through the use of new genetic tools, researchers are rapidly developing a better understanding of the basic science underlying sleep and wake behavior. Novel approaches that selectively target newly discovered systems related to insomnia have demonstrated efficacy in clinical studies. Some of these new approaches regulate sleep and wake behavior by taking advantage of the circadian rhythmicity of specific signaling systems in the central nervous system (CNS).
Because of the large volume of patients they manage, MCOs and other payers are in an excellent position to improve outcomes for patients with insomnia. By enhancing their knowledge of emerging science, pathophysiology, and emerging agents and by improving coordination of care, managed care professionals can reduce the health care burden associated with insomnia
Use knowledge of the underlying pathophysiology of sleep and wake behavior to recommend optimal treatments for patients with insomnia.
Explain new scientific approaches to regulate sleep and wake behavior through the circadian rhythmicity of signaling systems in the central nervous system.
Evaluate recent clinical studies on novel approaches for treating insomnia that selectively target newly discovered systems.
Outline the direct and indirect costs related to insomnia as a leading cause of absenteeism, accidents, and errors in the workplace.
Apply benefit design methodologies that MCOs can implement to improve the overall value for the treatment of insomnia.
Provide accurate and appropriate counsel as part of the treatment team.
Provide appropriate care and counsel for patients and their families.
Through the use of new genetic tools, researchers are rapidly developing a better understanding of the basic science underlying sleep and wake behavior. Novel approaches that selectively target newly discovered systems related to insomnia have demonstrated efficacy in clinical studies. Some of these new approaches regulate sleep and wake behavior by taking advantage of the circadian rhythmicity of specific signaling systems in the central nervous system (CNS).
Because of the large volume of patients they manage, MCOs and other payers are in an excellent position to improve outcomes for patients with insomnia. By enhancing their knowledge of emerging science, pathophysiology, and emerging agents and by improving coordination of care, managed care professionals can reduce the health care burden associated with insomnia
Use knowledge of the underlying pathophysiology of sleep and wake behavior to recommend optimal treatments for patients with insomnia.
Explain new scientific approaches to regulate sleep and wake behavior through the circadian rhythmicity of signaling systems in the central nervous system.
Evaluate recent clinical studies on novel approaches for treating insomnia that selectively target newly discovered systems.
Outline the direct and indirect costs related to insomnia as a leading cause of absenteeism, accidents, and errors in the workplace.
Apply benefit design methodologies that MCOs can implement to improve the overall value for the treatment of insomnia.
Provide accurate and appropriate counsel as part of the treatment team.
Provide appropriate care and counsel for patients and their families.
1.5 Free CEUs for Sleep Techs
Expires 6/30/15